Latest IMRIS Inc. Stories

WINNIPEG, Aug. 9, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS)(TSX: IM) ("IMRIS" or the "Company") today reported its results for the second quarter 2011.  All figures are reported in US dollars. 2011 Highlights: -- Q2 revenues increase 14% to $18.9 million -- Continuing solid order backlog of $97.5 million at June 30, 2011 versus $91.4 million a year earlier -- MR guided radiation therapy and robotics product development...

WINNIPEG, Aug. 4, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") today announced that it has received a Health Canada medical device license for AccuTrack(TM) the Company's 3D image guidance tool for use in IMRIS neurosurgery suites. AccuTrack(TM) represents a significant enhancement to the IMRIS image guided therapy suites. The new software-enabled capability aids surgeons in critical decision making by utilizing an ergonomic lightweight...

WINNIPEG, July 28, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) _____________________________________________________________________ |Second Quarter 2011 Earnings Release|August 9, 2011 | |____________________________________|________________________________| |Conference Call and Webcast |August 9, 2011 5:00 pm ET | |____________________________________|________________________________| |...

-- Investment in Product Development Accelerates -- WINNIPEG, May 12 /PRNewswire-FirstCall/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the first quarter 2011.  The results highlight continued progress in the execution of IMRIS's overall strategy, including the planned acceleration of product development investments. All figures are reported in US dollars. 2011 Highlights: -- IMRISNVsale to Utah's University...

WINNIPEG, May 4 /PRNewswire-FirstCall/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ___________________________________________________________________ |First Quarter 2011 EarningsRelease|May 12, 2011 | |__________________________________|________________________________| |Conference Call and Webcast |May 12, 2011 5:00 pm ET | |__________________________________|________________________________| |Hosted by...

--Leading stroke facility to study patient benefits -- WINNIPEG, March 28 /PRNewswire/ - (NASDAQ: IMRS) (TSX: IM) -- IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISNV to University of Utah Hospital in Salt Lake City, Utah. IMRISNV will provide important new capabilities for clinicians at University of Utah Hospital's leading edge stroke center. IMRISNV combines the imaging modalities of MR and fluoroscopy in a fully integrated suite to...

-- Net income of $1.7 million -- WINNIPEG, Feb. 14 /PRNewswire-FirstCall/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported its results for the fourth quarter 2010 highlighted by record financial performance that included strong revenue growth and the Company's second consecutive quarter of positive EBITDA(1) and earnings.  All figures are reported in Canadian dollars. Highlights: Record quarterly sales revenues of $25.2 million Record...

WINNIPEG, Feb. 3 /PRNewswire-FirstCall/ -IMRIS Inc. (NASDAQ: IMRS; TSX: IM) Fourth Quarter 2010 Earnings Release February 14, 2011 Conference Call and Webcast February 14, 2011 10:30 am ET Hosted by David Graves, Chairman and Chief Executive Officer; Kelly McNeill, Executive Vice President, Finance and Chief Financial Officer Participant Numbers 416-644-3414 or 1-800-814-4859 Conference Call ID Number 4407636 A question and answer session for analysts...

-- 3T system to be installed at NIH-funded clinical and research facility -- WINNIPEG, Nov. 29 /PRNewswire-FirstCall/ - (NASDAQ: IMRS; TSX: IM) -- IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISneuro to Dartmouth-Hitchcock Medical Center ("DHMC") in Lebanon, New Hampshire. IMRISneuro is a fully integrated multi-operating room system that features on-demand intraoperative MR imaging capabilities, designed to assist surgeons in improving outcomes for patients...

WINNIPEG, Nov. 19 /PRNewswire/ - IMRIS Inc. (TSX: IM; NASDAQ: IMRS) ("IMRIS" or the "Company") announced today that its common shares have commenced trading on the NASDAQ Global Market under the symbol "IMRS". IMRIS' common shares are dual listed on the Toronto Stock Exchange and the NASDAQ Global Market. In addition, IMRIS announced today the terms of its previously announced public offering of its common shares (the "Offering").  In connection with the Offering, IMRIS and a...